Elevance Health (ELV) Common Equity (2009 - 2026)

Elevance Health (ELV) has reported Common Equity for 18 consecutive years, with $45.0 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Common Equity rose 2.67% year-over-year to $45.0 billion in Q2 2026; TTM through Jun 2026 was $45.0 billion, a 2.67% increase from a year earlier, with the FY2025 full-year figure at $44.0 billion, up 6.28% from the prior year.
• Common Equity was $45.0 billion for Q2 2026 at Elevance Health, up from $44.0 billion in the prior quarter.
• Over five years, Common Equity peaked at $45.0 billion in Q2 2026 and troughed at $35.9 billion in Q2 2022.
• A 5-year average of $40.6 billion and a median of $41.1 billion in 2024 frame the typical range for Common Equity.
• Across the five-year window, Common Equity increased 13.86% in 2024 and grew 0.46% in 2025, its largest moves.
• Over 5 years, Common Equity stood at $36.3 billion in 2022, then advanced by 8.46% to $39.4 billion in 2023, then gained by 5.13% to $41.4 billion in 2024, then climbed by 6.28% to $44.0 billion in 2025, then increased by 2.26% to $45.0 billion in 2026.
• The last three Common Equity figures came in at $45.0 billion (Q2 2026), $44.0 billion (Q1 2026), and $44.0 billion (Q4 2025), per Business Quant data.